CD38 and plasma cell myeloma: For example, it is important to determine whether there is a preferential killing of CD38+ NK-cells over myeloma cells during bouts of exercise, and to assess this impact of exercise in a larger, more diverse cohort of patients before recommendations of exercise timing during therapy can be made.